ROSSINI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 782
EU - Europa 486
AS - Asia 117
SA - Sud America 3
OC - Oceania 2
AF - Africa 1
Totale 1.391
Nazione #
US - Stati Uniti d'America 772
PL - Polonia 153
IT - Italia 92
DE - Germania 56
CN - Cina 52
FI - Finlandia 42
UA - Ucraina 40
SE - Svezia 29
HK - Hong Kong 21
GB - Regno Unito 19
VN - Vietnam 18
BE - Belgio 16
FR - Francia 15
IN - India 15
IE - Irlanda 14
CA - Canada 9
SG - Singapore 6
RU - Federazione Russa 5
CL - Cile 3
JP - Giappone 3
AU - Australia 2
TH - Thailandia 2
CH - Svizzera 1
DK - Danimarca 1
GR - Grecia 1
NL - Olanda 1
NO - Norvegia 1
PA - Panama 1
TN - Tunisia 1
Totale 1.391
Città #
Warsaw 153
Fairfield 119
Ashburn 74
Seattle 72
Chandler 62
Houston 58
Woodbridge 55
Helsinki 41
Jacksonville 37
Cambridge 36
Brescia 35
New York 34
Wilmington 32
Princeton 26
West Jordan 24
Hong Kong 20
Dong Ket 18
Brussels 16
Ann Arbor 15
Beijing 14
Dublin 14
Dearborn 11
Pune 11
San Diego 7
Shanghai 7
Shenyang 6
Des Moines 5
Los Angeles 5
Nanchang 5
Nanjing 5
Rome 5
Cagliari 4
Milan 4
Naples 4
North York 4
Brooklyn 3
Gumyojicho 3
London 3
Norwalk 3
Zhengzhou 3
Berlin 2
Civitavecchia 2
Highland 2
Jinan 2
Leipzig 2
Ningbo 2
Ottawa 2
Phoenix 2
Pisogne 2
Rochester 2
San Donà Di Piave 2
San Francisco 2
San Mateo 2
Sant'anastasia 2
Toronto 2
Würzburg 2
Athens 1
Bengaluru 1
Borås 1
Cairate 1
Campogalliano 1
Canberra 1
Caserta 1
Changsha 1
Chicago 1
Cinisello Balsamo 1
Falkenstein 1
Flero 1
Florence 1
Fremont 1
Guangzhou 1
Hanover 1
Hounslow 1
Huizen 1
Kunming 1
Lanzhou 1
Lappeenranta 1
Livorno 1
Lutzingen 1
Melbourne 1
Oslo 1
Redwood City 1
Santiago 1
Singapore 1
Southwark 1
Taizhou 1
Tianjin 1
Tradate 1
Trumbull 1
Tunis 1
Turin 1
Venice 1
Wandsworth 1
Washington 1
Totale 1.123
Nome #
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 205
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 159
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 142
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 140
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 121
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 121
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 118
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 114
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 59
ESTROGEN AND PROGESTERONE RECEPTORS IN EXPERIMENTAL CELL MODELS OF HUMAN ADRENOCORTICAL CANCER: INTERACTION BETWEEN TAMOXIFENE AND PROGESTERONE 48
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 43
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 43
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 32
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 30
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 20
An update on adrenocortical cell lines of human origin 16
Caffeine inhibits Direct and Indirect Angiogenesis in zebrafish embryos 15
RETROSPECTIVE ANALYSIS OF THE PATIENT-REPORTED ADVERSE DRUG REACTIONS IN AN ITALIAN ALLERGY UNIT: ALLERG-RAF STUDY 4
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 4
Totale 1.434
Categoria #
all - tutte 6.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 13 18
2019/2020414 21 5 18 43 38 56 39 50 42 49 29 24
2020/2021329 16 25 25 39 28 26 18 26 26 48 19 33
2021/2022205 27 11 8 22 7 15 12 10 5 34 20 34
2022/2023176 27 15 14 15 19 28 4 19 23 0 3 9
2023/2024237 15 11 25 19 14 63 8 19 22 36 5 0
Totale 1.434